.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Fish and Richardson
Federal Trade Commission
Mallinckrodt
Citi
Medtronic
Argus Health
Johnson and Johnson
Daiichi Sankyo
Chinese Patent Office

Generated: December 15, 2017

DrugPatentWatch Database Preview

VENOFER Drug Profile

« Back to Dashboard

When do Venofer patents expire, and what generic alternatives are available?

Venofer is a drug marketed by Luitpold and is included in one NDA.

The generic ingredient in VENOFER is iron sucrose. There are seventy-seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the iron sucrose profile page.
Drug patent expirations by year for VENOFER

Pharmacology for VENOFER

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
LuitpoldVENOFERiron sucroseINJECTABLE;INTRAVENOUS021135-002Mar 20, 2005RXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
LuitpoldVENOFERiron sucroseINJECTABLE;INTRAVENOUS021135-001Nov 6, 2000RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
LuitpoldVENOFERiron sucroseINJECTABLE;INTRAVENOUS021135-005Mar 29, 2013DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LuitpoldVENOFERiron sucroseINJECTABLE;INTRAVENOUS021135-003Mar 29, 2005DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
LuitpoldVENOFERiron sucroseINJECTABLE;INTRAVENOUS021135-004Feb 9, 2007RXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Julphar
Colorcon
Moodys
Argus Health
Teva
Deloitte
Mallinckrodt
AstraZeneca
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot